Researchers have successfully used photosynthetic machinery extracted from spinach leaves to treat dry eye disease in mice, a finding that opens unexpected avenues for addressing one of the most common eye conditions.
The team applied specialized eye drops containing chloroplasts—the cellular structures responsible for photosynthesis in plants—directly to mouse eyes. The chloroplasts retained their ability to convert light into chemical energy even when separated from plant tissue. This metabolic activity generated oxygen and energy molecules that the eye tissues absorbed and used.
The approach targets a core problem in dry eye disease: insufficient oxygen and nutrient delivery to the ocular surface. By introducing photosynthetic machinery topically, the drops supplied both oxygen and ATP (adenosine triphosphate), the cell's primary energy currency. This combination appears to reduce inflammation and restore normal tear film stability.
In the mouse models tested, the photosynthetic eye drops outperformed standard saline treatments and conventional dry eye medications. Treated eyes showed improved tear production, reduced inflammatory markers, and faster healing of corneal damage compared to controls. The eyes remained their normal color throughout treatment, despite housing active plant chloroplasts.
The innovation carries practical advantages. Chloroplasts are readily available from common plants like spinach, making the therapy potentially inexpensive to manufacture. They are also biodegradable, eliminating concerns about foreign material accumulating in the eye. The photosynthetic process is self-sustaining when exposed to light, requiring no external power source.
Limitations remain before human trials begin. Mouse eyes differ substantially from human eyes in size, tear film composition, and immune response. Researchers must verify whether the treatment triggers adverse immune reactions in humans or whether chloroplasts survive long enough in the human tear film to deliver sufficient oxygen. They also need to determine optimal dosing and frequency.
The work builds on growing interest in harnessing biological systems for medical